Robert Ross Carter - 02 Jan 2026 Form 4/A - Amendment Insider Report for Oncology Institute, Inc. (TOI)

Role: Chief Financial Officer
Signature: /s/ Mark Hueppelsheuser, Attorney-in-fact for Robert Carter
Issuer symbol: TOI
Transactions as of: 02 Jan 2026
Net transactions value: -$895
Form type: 4/A - Amendment
Filing time: 06 Jan 2026, 16:30:02 UTC
Date Of Original Report: 05 Jan 2026
Previous filing: 19 Nov 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Carter Robert Ross	Chief Financial Officer	C/O THE ONCOLOGY INSTITUTE INC., 18000 STUDEBAKER RD #800, CERRITOS	/s/ Mark Hueppelsheuser, Attorney-in-fact for Robert Carter	06 Jan 2026	0002039341

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TOI	Common Stock	Other	$895	-244	-0.1%	$3.67	235,125	02 Jan 2026	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The Issuer executed the sale to cover the tax liabilities arising from the vesting of an RSU award on January 1, 2026.

Remarks:

This amended Form 4 is being filed to correct the Transaction Code, number of shares sold and sale price as reflected in the original filing made on January 5, 2026.